{"nct_id":"NCT03910660","title":"A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2023-03","start_date":"2019-02-12","start_date_type":"ACTUAL","primary_completion_date":"2023-10","primary_completion_date_type":"ESTIMATED","completion_date":"2025-12","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["BTAI"]}